You are viewing: US AI in Precision Medicine Market analysis

The US AI in Precision Medicine Market was valued at $18.69 Million in 2024 and projected to reach to $93.87 Million by 2029, representing a compound annual growth rate of 24.0%. The US AI in Precision Medicine Market is poised for exceptional growth through 2029, driven by increasing adoption of AI-powered diagnostic tools, genomic analysis platforms, and treatment optimization algorithms across major medical centers.

US AI in Precision Medicine Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US AI in Precision Medicine Market Trends and Insights

  • The US market is driven by advanced healthcare infrastructure, substantial R&D investments, and widespread adoption of AI-powered diagnostic and treatment solutions across major medical institutions.
  • The US leads in precision medicine innovation, with healthcare providers increasingly integrating machine learning algorithms for genomic analysis, drug discovery, and personalized treatment planning. The US market's 24.0% compound annual growth rate reflects strong demand from hospitals, diagnostic laboratories, and pharmaceutical companies seeking to enhance clinical outcomes through AI-enabled precision approaches.
  • In the US, regulatory support from the FDA and growing reimbursement policies are accelerating market penetration.
  • The US precision medicine ecosystem benefits from collaborations between tech companies, healthcare systems, and academic institutions, positioning the country as a global leader in AI-driven healthcare transformation through 2029..

Key Market Statistics

  • CAGR (2024-2029) 24.0% CAGR
  • Market Size, 2024 ~USD 18.69 Million
  • Forecast, 2029 ~USD 93.87 Million
  • Country US

US AI in Precision Medicine Market Overview

Market Valuation Growth :

The US AI in Precision Medicine Market is valued at $18.69 billion in 2024, with a robust 24% CAGR projected to reach $93.87 billion by 2029, significantly outpacing global adoption rates.

Advanced Healthcare Infrastructure :

The US benefits from world-leading healthcare systems, extensive EHR adoption, and sophisticated data analytics capabilities that accelerate AI integration in precision medicine applications across hospitals and clinics.

R&D Investment Leadership :

Major US pharmaceutical companies, biotech firms, and healthcare institutions invest heavily in AI-driven drug discovery, genomic sequencing, and personalized treatment protocols, establishing the nation as the innovation epicenter.

Regulatory Framework Maturity :

The FDA's established pathways for AI/ML medical devices and precision medicine approvals provide clarity for US companies, enabling faster commercialization compared to other global markets.

US AI in Precision Medicine Market Dynamics

  • Healthcare providers are leveraging machine learning to enhance patient stratification, reduce treatment costs, and improve clinical outcomes.
  • Significant venture capital funding and strategic partnerships between tech giants and healthcare organizations are accelerating innovation cycles.
  • Regulatory support from the FDA and growing reimbursement coverage for AI-enabled precision medicine services will further catalyze market expansion.
  • The convergence of big data analytics, cloud computing, and advanced AI models positions the US market to capture substantial value in personalized oncology, cardiology, and rare disease management..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Danaher Corporation

    Analytical And Scientific Instrumentation

    Top Technologies
    • Environmental Testing
    • Gas Chromatography
    • Polymerase Chain Reaction (PCR)
    • Automated Liquid Handling Systems
    • Flow Cytometry
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Shimadzu Corporation
    • Merck KGaA

      Healthcare Analytics

      Top Technologies
      • Machine Learning
      • Natural Language Processing (NLP)
      • Blood Pressure Monitors
      • Computed Tomography (CT)
      • Magnetic Resonance Imaging (MRI)
      Top Companies
      • Oracle Corporation
      • PHILIPS HEALTHCARE
      • Siemens healthineers
      • Zensar Technologies Limited
      • EPIC SYSTEMS CORPORATION

        Key Takeaways

        • The US AI in Precision Medicine Market will grow from $18.69B (2024) to $93.87B (2029), representing a 24.0% CAGR.
        • The US healthcare system's advanced infrastructure and FDA regulatory framework are primary catalysts for AI precision medicine adoption.
        • The US market is characterized by strong investment from major pharmaceutical and healthcare technology companies developing AI-driven diagnostic platforms.
        • The US precision medicine sector is expanding across oncology, cardiology, and rare disease diagnosis, driven by personalized treatment demand.

        AI in Precision Medicine Market Report Scope

        Report Metric Details
        Base Year 2024
        Fastest Growing Segment IMAGE ANALYSIS (Tool)
        Forecast Period 2024-2029
        Growth Rate CAGR of 30.7% from 2024 to 2029
        Largest Segment SOFTWARE (Component)
        Market Size Base Year (Billions) ~USD 0.79 (2024)
        Revenue Forecast (Billions) ~USD 3.92 (2029)
        Segments Covered Application, Type, Therapeutic Area, Component, Tool, Deployment, End User, Deployment 2022-2030

        US AI in Precision Medicine Market Report Segmentation

        8 segment dimensions are covered across the global market.

        By Application

        • Clinical Development
        • De Novo Drug Design
        • Diagnostic & Screening
        • Diagnostics & Screening
        • Drug Discovery
        • Drug Discovery & Development
        • Drug Optimization
        • Drug Repurposing
        • Safety
        • Therapeutics
        • Understanding Diseases

        By Type

        • Deep Learning
        • Disease Diagnosis
        • Disease Progression, Staging & Prognosis
        • Disease Screening
        • Other Machine Learning Types
        • Post Treatment Surveillance & Follow-Up
        • Reinforcement Learning
        • Risk Assessment & Patient Stratification
        • Supervised Learning
        • Therapy Monitoring
        • Therapy Selection & Planning
        • Unsupervised Learning

        By Therapeutic Area

        • Cardiology
        • Hematology
        • Infectious Diseases
        • Neurology
        • Oncology
        • Other Therapeutic Area
        • Other Therapeutic Areas
        • Rare Disease
        • Rare Diseases

        By Component

        • Services
        • Software

        By Tool

        • Computer Vision
        • Context Aware Processing
        • Context-Aware Processing
        • Context-Aware Processing & Computing
        • Image Analysis
        • Machine Learning
        • Natural Language Processing
        • Nlp
        • Other Tools

        By Deployment

        • Cloud-Based
        • Cloud-Based Model
        • Hybrid
        • Hybrid Model
        • On-Premise
        • On-Premise Model

        By End User

        • Healthcare Providers
        • Medical Device/Equipment Companies
        • Other End Users
        • Pharmaceutical & Biotechnology Companies
        • Research Centers, Academic Institutes & Government Organizations
        • Research Centers, Academic Institutes, & Government Organizations

        By Deployment 2022-2030

        • Cloud Based
        • Cloud-Based
        • Hybrid
        • On-Premise

        US: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030

        Segment202220232024202520262027202820292030CAGR (%)
        HEALTHCARE PROVIDERS52.9671.0295.19127.54170.81228.69306.05409.42547.5133.9
        MEDICAL DEVICE/EQUIPMENT COMPANIES32.1542.9257.2776.39101.85135.74180.85240.86320.6533.3
        OTHER END USERS11.9615.8220.927.6136.4648.1263.583.75110.4332
        PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES43.5957.1874.9798.25128.72168.56220.66288.74377.6830.9
        RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS25.332.9242.8255.6772.3493.97122.01158.36205.4729.9
        TOTAL165.97219.85291.15385.45510.18675.08893.061181.141561.7532.3

        Target Audience

        • Healthcare Technology Investors : Venture capital and private equity firms seeking high-growth opportunities in the US AI healthcare sector need validated market sizing, competitive dynamics, and exit potential analysis for precision medicine investments.
        • Pharmaceutical & Biotech Executives : C-suite leaders at US pharma and biotech companies require market intelligence on AI adoption trends, competitive threats, and partnership opportunities to inform R&D strategy and precision medicine initiatives.
        • Healthcare System Administrators : Hospital networks and health systems evaluating AI precision medicine solutions need market data on vendor capabilities, implementation costs, clinical ROI, and reimbursement landscape to guide procurement decisions.
        • AI & Software Solution Providers : Technology companies developing AI platforms for healthcare need US-specific market insights, customer segments, regulatory requirements, and competitive positioning to optimize go-to-market strategies.
        • Medical Device & Diagnostics Companies : Manufacturers of diagnostic tools and medical devices require market forecasts, clinical adoption rates, and reimbursement trends in the US to align product development and commercialization roadmaps.

        Reasons to Buy this Report

        • Market Size & Growth Validation : Comprehensive data validating the US market's $18.69B valuation and 24% CAGR trajectory through 2029, enabling confident strategic planning and investment decisions for market participants.
        • Competitive Landscape Intelligence : Detailed analysis of leading US healthcare systems, AI vendors, and biotech companies driving precision medicine adoption, identifying key competitors and partnership opportunities specific to the American market.
        • Regulatory & Reimbursement Insights : In-depth understanding of FDA approval pathways, Medicare/insurance reimbursement trends, and compliance requirements unique to the US market, reducing commercialization risks for new solutions.
        • Segment & Application Breakdown : Granular market segmentation by therapeutic area (oncology, cardiology, rare diseases), technology type (diagnostics, drug discovery, treatment planning), and end-user verticals specific to US healthcare delivery.
        • Strategic Growth Opportunities : Actionable insights on emerging use cases, underserved patient populations, and high-ROI investment areas within the US precision medicine ecosystem to guide market entry and expansion strategies.

        Frequently asked questions

        What is the current size of the US AI in Precision Medicine Market?

        The US AI in Precision Medicine Market was valued at $18.69 billion in 2024 and is expected to grow to $93.87 billion by 2029.

        What is the growth rate of the US AI in Precision Medicine Market?

        The US market is projected to grow at a compound annual growth rate (CAGR) of 24.0% from 2024 to 2029.

        What are the main drivers of growth in the US AI in Precision Medicine Market?

        Key drivers include advanced healthcare infrastructure, FDA regulatory support, increased R&D investments, growing reimbursement policies, and rising demand for personalized treatment solutions across US healthcare institutions.

        Which medical specialties are leading AI adoption in the US precision medicine market?

        Oncology, cardiology, and rare disease diagnosis are among the leading specialties driving AI precision medicine adoption in the US, supported by the need for personalized treatment approaches.

        How is the US regulatory environment supporting AI in precision medicine?

        The US FDA provides regulatory pathways for AI-driven diagnostic and therapeutic tools, while growing reimbursement policies from insurance providers are accelerating market adoption and investment in precision medicine solutions.

        RESEARCH METHODOLOGY

        The study involved significant activities to estimate the current size of the AI in precision medicine market. Exhaustive secondary research was done to collect information on the AI in precision medicine market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the AI in precision medicine market.

        Secondary Research

        This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for the companies offering AI in precision medicine solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases.

        Various secondary sources were referred to in the secondary research process to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of AI in precision medicine vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

        Primary Research

        In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the AI in precision medicine market.

        After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also undertaken to identify the segmentation types, industry trends, competitive landscape of AI in precision medicine solutions offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies.

        In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

        Breakdown of Primary Participants:

        AI in Precision Medicine Market

        Note 1: Others include sales managers, marketing managers, and product managers.

        Note 2: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        Both top-down and bottom-up approaches were used to estimate and validate the total size of the AI in precision medicine market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

        • The key players in the industry and markets have been identified through extensive secondary research.
        • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
        • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
        AI in Precision Medicine Market

        Data Triangulation

        After arriving at the overall market size using the market size estimation processes explained above, the market was split into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

        Market Definition

        The AI in precision medicine market utilises AI technologies such as machine learning and natural language processing to analyse complicated biological and clinical data in order to provide possibly personalised healthcare solutions. It promotes applications such as drug discovery, diagnostics, predictive analytics, and tailored treatment plans by integrating genomics, proteomics, and real-world data using AI capabilities with the goal of improving patient outcomes and accelerating innovation benefits for stakeholders ranging from pharmaceutical companies and healthcare providers to researchers.

        Stakeholders

        • Transfection products manufacturing companies
        • Pharmaceutical & Biopharmaceutical Companies
        • Chemical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations (CROs)
        • Contract Development and Manufacturing Organizations (CDMOs)
        • Research Institutes and Universities 
        • Venture Capitalists & Investors
        • Government Associations

        Report Objectives

        • To define, describe, and forecast the AI in precision medicine market based on application, therapeutic area, component, tools, deployment, end user, and region.
        • To provide detailed information about the major factors (drivers, opportunities, restraints, and challenges) influencing the growth of the market
        • To analyze opportunities for stakeholders by identifying the high-growth segments of the market
        • To forecast the size of the market segments with respect to five main regions: North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
        • To analyze subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market
        • To profile the key players and comprehensively analyze their market sizes and core competencies.
        • To track and analyze competitive developments such as acquisitions, collaborations, agreements, mergers, product launches & updates, partnerships, expansions, and other recent developments in the market globally.

        Get the Full AI in Precision Medicine Market Report

        Full forecast, segment splits, and company analysis for all AI in Precision Medicine Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status